Strategies for single base gene editing in an immortalized human cell line by CRISPR/Cas9 technology

被引:1
|
作者
Corrado, Alda [1 ]
Aceto, Romina [1 ,2 ]
Miglietta, Simona [3 ]
Silvestri, Roberto [1 ]
Dell'Anno, Irene [1 ]
Lepori, Irene [4 ]
Ricci, Benedetta [5 ]
Romei, Cristina [6 ]
Giovannoni, Roberto [1 ]
Poliseno, Laura [4 ]
Evangelista, Monica [4 ]
Vitiello, Marianna [4 ]
Cipollini, Monica [1 ]
Elisei, Rossella [6 ]
Landi, Stefano [1 ]
Gemignani, Federica [1 ]
机构
[1] Univ Pisa, Dept Biol, Genet Unit, Via Derna 1, I-56126 Pisa, Italy
[2] Humanitas Clin & Res Ctr IRCCS, Via Manzoni 56, I-20089 Milan, Italy
[3] IRCCS San Raffaele Sci Inst, San Raffaele Telethon Inst Gene Therapy SR Tiget, Via Olgettina 60, I-20132 Milan, Italy
[4] CNR, Inst Clin Physiol IFC, Via Giuseppe Moruzzi 1, I-56124 Pisa, Italy
[5] Fdn IRCCS Ist Neurol Carlo Besta, Via Celoria 11, I-20133 Milan, Italy
[6] Univ Pisa, Dept Clin & Expt Med, Endocrine Unit, Via Paradisa 2, I-56124 Pisa, Italy
关键词
CRISPR/Cas9; Knock-in; Human cell lines; Single base DNA editing; Double nickase strategy;
D O I
10.1007/s13205-023-03878-4
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The use of CRISPR/Cas9 system has rapidly grown in the last years. Here, the optimization of gene editing of a single-nucleotide polymorphism in a human non-malignant somatic cell line of thyrocytes (Nthy-Ori) was described highlighting strategies for overcoming the problems concerning the delivery and off-targets. We employed both lentivirus and chemical lipids as delivery agents and two strategies for creating the double-strand breaks (DSB). The former induced a DSB by a classical Cas9 nuclease (standard strategy), while the second one employed a modified Cas9 creating a single-strand break (SSB). The knock-in was carried out using a single-stranded donor oligonucleotide or the HR410-PA donor vector (HR). The desired cells could be obtained by combining the double nickase system with the HR vector transfected chemically. This result could be due to the type of DSB, likely processed mainly by non-homologous end joining when blunt (standard strategy) and by HR when overhanging (double nickase). Our results showed that the double nickase is suitable for knocking-in the immortalized Nthy-Ori cell line, while the standard CRISPR/Cas9 system is suitable for gene knock-out creating in/del mutations.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Lipid and polymer mediated CRISPR/Cas9 gene editing
    Gong, Yan
    Tian, Siyu
    Xuan, Yang
    Zhang, Shubiao
    JOURNAL OF MATERIALS CHEMISTRY B, 2020, 8 (20) : 4369 - 4386
  • [42] Gene editing using CRISPR/Cas9 in neuromuscular disorders
    Gonorazky, H.
    Maani, N.
    Khattak, S.
    Ivakine, Z.
    Cohn, R.
    Dowling, J.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S127 - S127
  • [43] Delivery methods for CRISPR/Cas9 gene editing in crustaceans
    Sen Xu
    Thinh Phu Pham
    Swatantra Neupane
    Marine Life Science & Technology, 2020, 2 : 1 - 5
  • [44] Fanconi Anemia Gene Editing by the CRISPR/Cas9 System
    Osborn, Mark J.
    Gabriel, Richard
    Webber, Beau R.
    DeFeo, Anthony P.
    McElroy, Amber N.
    Jarjour, Jordan
    Starker, Colby G.
    Wagner, John E.
    Joung, J. Keith
    Voytas, Daniel F.
    von Kalle, Christof
    Schmidt, Manfred
    Blazar, Bruce R.
    Tolar, Jakub
    HUMAN GENE THERAPY, 2015, 26 (02) : 114 - 126
  • [45] CRISPR/Cas9 gene editing special issue INTRODUCTION
    Doench, John G.
    FEBS JOURNAL, 2016, 283 (17) : 3160 - 3161
  • [46] Development of an Efficient Genome Editing Method by CRISPR/Cas9 in a Fish Cell Line
    Dehler, Carola E.
    Boudinot, Pierre
    Martin, Samuel A. M.
    Collet, Bertrand
    MARINE BIOTECHNOLOGY, 2016, 18 (04) : 449 - 452
  • [47] Generation of a Foxc2 Gene Knockout Murine Melanoma Cell Line via CRISPR Cas9 Genome Editing Technology
    Thompson, Jefferson
    Hargadon, Kristian
    FASEB JOURNAL, 2016, 30
  • [48] Engineering Single-Cycle Measles Vector for CRISPR/Cas9 Gene Editing
    Rallabandi, Naga Sai Ramya
    Sharp, Brenna
    Majerus, Spencer
    Hoffer, Sarriana
    Mia, Ikeda
    Devaux, Patricia
    MOLECULAR THERAPY, 2024, 32 (04) : 109 - 109
  • [49] Development of an Efficient Genome Editing Method by CRISPR/Cas9 in a Fish Cell Line
    Carola E. Dehler
    Pierre Boudinot
    Samuel A. M. Martin
    Bertrand Collet
    Marine Biotechnology, 2016, 18 : 449 - 452
  • [50] ESTABLISHMENT OF A ΔF508 NEUTROPHIL PRECURSOR CELL LINE USING CRISPR/CAS9 GENE EDITING
    Jennings, S.
    Ng, H.
    Wang, G.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S285 - S285